Haloperidol - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:56:23Z

Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T17:24:23Z

Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

2026-03-20T16:42:31Z

Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

← Older revision		Revision as of 16:42, 20 March 2026
Line 79:		Line 79:
	==Comments==		==Comments==



			==Indications by Condition==
			''The following table is automatically generated from disease/condition pages across WikEM.''

			{{#ask:[[Has DrugName::Haloperidol]]
			\|?Has Indication=Indication
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|?Has Route=Route
			\|?Has Population=Population
			\|format=broadtable
			\|headers=plain
			\|link=subject
			\|sort=Has Indication
			\|limit=50
			}}

	==See Also==		==See Also==

2022-05-12T20:08:48Z

← Older revision		Revision as of 20:08, 12 May 2022
Line 5:		Line 5:

	==Adult Dosing==		==Adult Dosing==
	*Acute Agitation:		*Acute [[Agitation]]:
	**5-10mg IM, subsequent doses based on patient response dosed every 1 hour		**5-10mg IM, subsequent doses based on patient response dosed every 1 hour
	**0.5-10mg IV, depending on degree of agitation; may repeat bolus dose (with sequential doubling of initial bolus dose) q15-30mins until calm achieved		**0.5-10mg IV, depending on degree of agitation; may repeat bolus dose (with sequential doubling of initial bolus dose) q15-30mins until calm achieved

	*Psychosis:		*[[Psychosis]]:
	**0.5-2mg PO divided BID-TID, slowly titrate q7days to effect with Max 100mg/day		**0.5-2mg PO divided BID-TID, slowly titrate q7days to effect with Max 100mg/day

2021-03-07T04:05:28Z

2019-09-22T20:19:20Z

References

2017-10-13T15:17:39Z

Contraindications

2016-12-31T20:22:41Z

← Older revision		Revision as of 20:22, 31 December 2016
Line 40:		Line 40:
	==Special Populations==		==Special Populations==
	*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]: C		*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]: C
	*[[~~Lactation risk categories~~\|Lactation risk]]: ~~unknown, likely L4~~		*[[Pregnancy and lactation drug labeling\|Lactation risk]]: Unknown
	*Renal Dosing		*Renal Dosing
	**Adult - none		**Adult - none
Line 51:		Line 51:
	*Allergy to class/drug		*Allergy to class/drug
	*Parkinson's Disease		*Parkinson's Disease
	*Depressed mental status/comotose

	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===
	*[[Prolonged QT]]->[[Torsades de pointes]]->Sudden Death		*[[Prolonged QT]] → [[Torsades de pointes]] → Sudden Death
	*[[Hypotension]]		*[[Hypotension]]
	*[[Neuroleptic malignant syndrome]]		*[[Neuroleptic malignant syndrome]]
Line 78:		Line 77:

	==Comments==		==Comments==


	==See Also==		==See Also==


	==References==		==References==
	<references/>		<references/>

	[[Category:Pharmacology]]		[[Category:Pharmacology]]

2016-07-30T03:40:56Z

General

← Older revision		Revision as of 03:40, 30 July 2016
Line 1:		Line 1:
	==General==		==General==
	*Type: ~~Typical antipsychotic~~		*Type: [[Antipsychotic]], first generation
	*Dosage Forms: PO, IM, IV		*Dosage Forms: PO, IM, IV
	*Common Trade Names: Haldol		*Common Trade Names: Haldol

2016-03-22T15:53:31Z

Text replacement - "Category:Drugs" to "Category:Pharmacology"